Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Mild”

1,480 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,480 results

Very early researchStudy completedNCT03926702
What this trial is testing

Tau Imaging With JNJ067

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentProgressive Supranuclear Palsy
University of California, Berkeley 18
Not applicableStudy completedNCT05675137
What this trial is testing

Efficacy of a Mobile-based Multidomain Intervention to Improve Cognitive Function and Health-related Outcomes Among Older Korean Adults With a High Risk of Dementia

Who this might be right for
Cognitive DeclineCognitive Impairment, MildAging+1 more
Silvia Health 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05463731
What this trial is testing

Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,667
Not applicableLooking for participantsNCT03020381
What this trial is testing

Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study

Who this might be right for
Gait ApraxiaMild Cognitive ImpairmentSubjective Cognitive Impairment+3 more
Manuel Montero Odasso 600
Testing effectiveness (Phase 2)Study completedNCT05081219
What this trial is testing

SNIFF - Combo INI+EMPA Trial

Who this might be right for
Mild Cognitive ImpairmentCognitive ImpairmentAlzheimer Disease
Wake Forest University Health Sciences 47
Not applicableWithdrawnNCT06856681
What this trial is testing

Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease

Who this might be right for
Alzheimers Disease
C2N Diagnostics
Testing effectiveness (Phase 2)Study completedNCT03305809
What this trial is testing

LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)

Who this might be right for
Lewy Body Dementia
Eli Lilly and Company 344
Not applicableStudy completedNCT04513106
What this trial is testing

Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial

Who this might be right for
Dementia MildMild Cognitive Impairment
Hong Kong Metropolitan University 36
Not applicableUnknownNCT05104593
What this trial is testing

An Integrated Solution for Sustainable Care for Multimorbid Elderly Patients With Dementia

Who this might be right for
Comorbidities and Coexisting ConditionsAlzheimer DiseaseDementia+12 more
Complejo Hospitalario Universitario de Albacete 204
Not applicableNot Yet RecruitingNCT07391436
What this trial is testing

Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease Dementia
Getúlio Vargas University Hospital 150
Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT00733863
What this trial is testing

Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.

Who this might be right for
Alzheimer Disease
Novartis 27
Post-approval studies (Phase 4)Enrolling By InvitationNCT05514106
What this trial is testing

MIBG in Aging and Neurologic Disorders

Who this might be right for
Lewy Body DiseaseDementiaParkinsonism+2 more
Mayo Clinic 50
Not applicableNot Yet RecruitingNCT06825663
What this trial is testing

Marker of Brain Insulin Resistance in AD Prognosis

Who this might be right for
Prognosis Biomarker of ADMild Cognitive ImpairmentBrain Insuline Resistance
Central Hospital, Nancy, France 122
Testing effectiveness (Phase 2)Study completedNCT02228187
What this trial is testing

Brain-Computer Interface System for Training Memory and Attention in Elderly

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentAge-Related Cognitive Decline+1 more
Duke-NUS Graduate Medical School 240
Testing effectiveness (Phase 2)Study completedNCT01284387
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Not applicableStudy completedNCT01264614
What this trial is testing

Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults

Who this might be right for
Cognitive DeclineDementiaAlzheimer's Disease+1 more
Union College, New York 22
Not applicableStudy completedNCT02050464
What this trial is testing

Computational Tools for Early Diagnosis of Memory Disorders

Who this might be right for
Alzheimer DiseaseFrontotemporal DementiaDementia, Vascular+1 more
University of Eastern Finland 126
Not applicableLooking for participantsNCT07237009
What this trial is testing

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Who this might be right for
Neurocognitive Disorders, MildCognitive Impairment, MildDepression Mild+2 more
KompanionCare SAS 80
Large-scale testing (Phase 3)Study completedNCT00053599
What this trial is testing

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA) 400
Load More Results